We offer a novel tool for antibiotic treatment. Our approach targets a broad spectrum of bacteria but eliminates the risk of evolving resistance by targeting a multitude of pathways.

Senfina offers in vivo whole life drug discovery services for aging and age-related diseases based on a multi-feature high-throughput imaging platform using C. elegans as a model organism.

We have discovered new class of therapeutics that reduce the rate of cell growth in cancer and vascular lung diseases.

An EVD or external ventricular drain, is a device used in neurosurgery to relieve intracranial pressure (ICP) resulting from a disturbance in cerebrospinal fluid (CSF) drainage due to tumors, cysts, bleeding, infection, hydrocephalus, and trauma. Existing EVD’s are manually assembled so as to insure appropriate drainage and ICP. Unfortunately, these systems are labor intensive and require full time monitoring by the medical staff.

Using today’s electronic devices and sensors, we have designed an EVD that can provide a completely autonomous solution while providing accuracy and repeatability.

The SeVA platform is a composite AI device that can be effectively deployed in hospital, nursing homes and home settings. It has the capability to track a patient’s mental and physical state and signal early signs of risks such as delirium, falls or impending illness. It provides emotional support to the patient and their family by indulging in a natural conversation and facilitating their needs. When fully deployed, the product can serve as a platform which allays worry for people and their caregivers and will reduce healthcare costs by identifying the early signs of severe illness.

The Atmospherica process utilizes naturally occurring, photosynthetic, shell-forming micro-algae to sequester CO2 and store it as calcium carbonate, a highly durable mineral that is stable for millions of years. It is a safe and relatively easy process that can be implemented quickly and cost effectively.

Our novel gene editing removes the immunogenicity of human Pluripotent Stem Cells upon implantation into human organs. We have chosen Type 1 Diabetes as the initial indication to demonstrate the potential of our platform.

University of Arizona researchers have developed a safe, edible food sanitizer to eliminate both foodborne and spoilage microorganisms, greatly reducing food illnesses and increasing shelf-life.